Efficacy of Cal-Cemex as bone substitute for tibial plateau fractures.

Category: Scientific Paper

Efficacy of Cal-Cemex as bone substitute for tibial plateau fractures.

Publication date: 14/02/24

Share on

Contact us

Do you want to get in direct contact with us?

Authors

Pizzoli A, Bondi M, Piotto L,
Tartaglia N, Saracino M, Vyrva O

Institute

Hospital Carlo Poma, Mantua - Italy
Hospital Miulli, Acqua Viva delle Fonti (Bari) – Italy
Hospital Sytenko, Kharkiv - Ukraine

Journal

J Orthop Surg Res. 2023 Nov 6;18(1):836.

Take Home message

Early full weight-bearing (35 days)
No complications
Open or closed surgery with locking compression plate (LCP) or cannulated screws (CS)
Evidence of osteointegration and bone ingrowth at 1Y

Study details		Score	Range
Subject	Clinical	-	-
Type	Retrospective study	1	1 - 5
Journal	International Orthopedics	3	1 - 3

Summary

45 tibial plateau fractures treated with Cal-Cemex and osteosynthesis. Multi-center study (3); mean follow-up of 43M Sample characteristics 44 patients (27 F, 17 M), age 56 Y (26 – 82) All pts received Cal-Cemex in association with LCP (29) or CS (16). Cal-Cemex was used before or after application of osteosynthesis device. Fractures type according to Schtzker: 13 type II, 24 type III, 3 type V and 4 type VI Follow Up (range) 42.8 M (12 - 70)

Results

Functional outcome at 1Y

Rasmussen knee function score: 24.7 (18 – 29)
KOOS score: 90.7 (65 – 100)
HSS knee score: 89.9 (70 – 90)

Full weight-bearing

34.9 days (30 – 60)

Complications at 1Y

No cement leakage, complex regional pain syndrome, neuroma or exostosis formation.
No deep infection or local inflammatory reaction.
No soft tissue complication such as wound infection or dehiscence.
No reoperation or implant removal.
No screw loosening or fracture reduction loss

CT scan at 1Y

Good surface osteointegration, without radiolucent lines or osteolysis with evidence of interdigitation and bone ingrowth.

Key points

Early full weight-bearing (osteosynthesis stability due to mechanical performances of Cal-Cemex)
Possibility of percutaneous application
No complications
Good functional outcome

Find out more about Cal-Cemex

Score

Study value	*	* *	* * *	* * * *	* * * * *
Description	Retrospective study	Retrospective comparative Retrospective Register study	Prospective study Systematic review Meta-analysis	Randomized controlled trial (RCT)	Systematic review of RCT

Journal value	*	* *	* * *
Description	Low impact factor (<1.500)	Medium impact factor (>1.500 – <2.500)	High impact factor (> 2.500)

Read the abstract on PubMed